Skip to content

Impact of preoperative weight loss case management on the perioperative period of obese patients with pulmonary nodules

Impact of preoperative weight loss case management on the perioperative period of obese patients with pulmonary nodules

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059991
Enrollment
Unknown
Registered
2022-05-14
Start date
2022-05-20
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary nodules

Interventions

1:Preoperative weight loss case management: therapeutic lifestyle intervention + semaglutide

Sponsors

The First Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Fully understand the purpose and requirements of this study, sign the informed consent form and have good compliance. 2. Patients who meet one of the following conditions: 1) 18-75 years old; 2) BMI = 28, obese or overweight; 3) Patients who have to undergo surgery, have pulmonary nodules less than 2cm, have no infiltration or malignant manifestations and can wait 1-3 months according to the same expert.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications of smectide, such as medullary thyroid carcinoma and type 2 multiple endocrine tumor syndrome; 2. Diagnosed diabetes patients; 3. Patients who have been allergic to GLP-1 analogues in the past; 4. Pulmonary resection has been performed in the past; 5. Active enteritis or gastritis, gastrointestinal ulcer or bleeding, after gastrointestinal surgery; 6. Have been treated with GLP-1 analogues within 90 days; 7. Pregnancy or lactation; 8. Other malignant diseases that affect the survival of patients, such as severe immune diseases; 9. The situation that the investigators think is not suitable for recruitment.

Design outcomes

Primary

MeasureTime frame
Perioperative complication rate;patients reported outcomes;Pulmonary Function;

Secondary

MeasureTime frame
length of staying;

Countries

China

Contacts

Public ContactAilan Chen

The First Hospital of Guangzhou Medical University

1228327958@qq.com+86 13719198832

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026